Walsh, Sharon L.

Clinical pharmacology of buprenorphine: Ceiling effects at high doses

Walsh, S. L., Preston, K. L., Stitzer, M. L., Cone, E. J., & Bigelow, G. E. (1994) · Clinical Pharmacology and Therapeutics

Opioid Use Disorder TreatmentPain Management and Opioid Use

Cited by 773

Opioid use disorder

Strang, J., Volkow, N. D., Degenhardt, L., Hickman, M., Johnson, K., Koob, G. F., Marshall, B. D. L., Tyndall, M., & Walsh, S. L. (2020) · Nature Reviews Disease Primers

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 639

A Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid Dependence

Johnson, R. E., Chutuape, M. A., Strain, E. C., Walsh, S. L., Stitzer, M. L., & Bigelow, G. E. (2000) · New England Journal of Medicine

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 623

Gabapentin misuse, abuse and diversion: A systematic review

Smith, R. V., Havens, J. R., & Walsh, S. L. (2016) · Addiction

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 378

Cannabidiol: pharmacology and therapeutic targets

Britch, S. C., Babalonis, S., & Walsh, S. L. (2021) · Psychopharmacology

Cannabis and Cannabinoid ResearchEpilepsy research and treatment

Cited by 307

Acute administration of buprenorphine in humans: partial agonist and blockade effects.

Walsh, S. L., Preston, K. L., Bigelow, G. E., & Stitzer, M. L. (1995) · The Journal of Pharmacology and Experimental Therapeutics

Opioid Use Disorder TreatmentPain Management and Opioid Use

Cited by 283

Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans

Walsh, S., Strain, E., Abreu, M., & Bigelow, G. (2001) · Psychopharmacology

Neuropeptides and Animal PhysiologyPain Management and Opioid Use

Cited by 258

Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis.

Haney, M., Malcolm, R. J., Babalonis, S., Nuzzo, P. A., Cooper, Z. D., Bedi, G., Gray, K. M., McRae-Clark, A., Lofwall, M. R., Sparenborg, S., et al. (2016) · Neuropsychopharmacology

Cannabis and Cannabinoid ResearchForensic Toxicology and Drug Analysis

Cited by 206

A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.

Gray, K. M., Sonne, S. C., McClure, E. A., Ghitza, U. E., Matthews, A. G., McRae-Clark, A. L., Carroll, K. M., Potter, J. S., Wiest, K., Mooney, L. J., et al. (2017) · Drug and Alcohol Dependence

Substance Abuse Treatment and OutcomesCannabis and Cannabinoid Research

Cited by 157

Elimination of Cocaine and Metabolites in Plasma, Saliva, and Urine Following Repeated Oral Administration to Human Volunteers

Jufer, R. A., Wstadik, A., Walsh, S. L., Levine, B. S., & Cone, E. J. (2000) · Journal of Analytical Toxicology

Forensic Toxicology and Drug AnalysisPharmacogenetics and Drug Metabolism

Cited by 137

Treatment of opioid overdose: current approaches and recent advances

Britch, S. C., & Walsh, S. L. (2022) · Psychopharmacology

Opioid Use Disorder TreatmentPoisoning and overdose treatments

Cited by 96

The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusers

Middleton, L. S., Nuzzo, P. A., Lofwall, M. R., Moody, D. E., & Walsh, S. L. (2011) · Addiction

Opioid Use Disorder TreatmentPain Management and Opioid Use

Cited by 77

The prevalence of opioid use disorder in Kentucky’s counties: A two-year multi-sample capture-recapture analysis

Thompson, K., Barocas, J. A., Delcher, C., Bae, J., Hammerslag, L., Wang, J., Chandler, R., Villani, J., Walsh, S., & Talbert, J. (2023) · Drug and Alcohol Dependence

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 39

Extended-Release Injection vs Sublingual Buprenorphine for Opioid Use Disorder With Fentanyl Use: A Post Hoc Analysis of a Randomized Clinical Trial

Nunes, E. V., Comer, S. D., Lofwall, M. R., Walsh, S. L., Peterson, S., Tiberg, F., Hjelmstrom, P., & Budilovsky-Kelley, N. R. (2024) · JAMA Network Open

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 25

Relative Potency of levo-α-Acetylmethadol and Methadone in Humans under Acute Dosing Conditions

Eissenberg, T., Stitzer, M. L., Bigelow, G. E., Buchhalter, A. R., & Walsh, S. L. (1999) · The Journal of Pharmacology and Experimental Therapeutics

Pain Management and Opioid UseOpioid Use Disorder Treatment

Cited by 14